| Literature DB >> 27634765 |
Peiling Tsou1, Hiroyuki Katayama1, Edwin J Ostrin1, Samir M Hanash2.
Abstract
There is increasing evidence supporting a role for B cells in tumor immunology. Paraneoplastic syndromes occurring before a cancer diagnosis have pointed to the potential for harnessing the humoral immune response for early cancer detection. The presence of tumor-infiltrating B lymphocytes has been linked to a favorable clinical outcome in many types of cancers. However, B cells represent a heterogeneous population with functionally distinct subsets, and the balance among subtypes impacts tumor development. Here, we review recent findings related to B cells and to the humoral immune response in cancer and their translational significance. Cancer Res; 76(19); 5597-601. ©2016 AACR. ©2016 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27634765 DOI: 10.1158/0008-5472.CAN-16-0431
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701